Journal
JOURNAL OF IMMUNOLOGY
Volume 185, Issue 4, Pages 2458-2466Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0902153
Keywords
-
Categories
Funding
- Canadian Institutes for Health Research
- Multiple Sclerosis Society of Canada
- Danish Multiple Sclerosis Society
- Johnsen and Hustrus Mindelegat
- Novo Nordisk Foundation
Ask authors/readers for more resources
Inflammatory responses are essential for immune protection but may also cause pathology and must be regulated. Both Th1 and Th17 cells are implicated in the pathogenesis of autoimmune inflammatory diseases, such as multiple sclerosis. We show in this study that IL-18-binding protein (IL-18bp), the endogenous inhibitor of the Th1-promoting cytokine IL-18, is upregulated by IFN-gamma in resident microglial cells in the CNS during multiple sclerosis-like disease in mice. Test of function by overexpression of IL-18bp in the CNS using a viral vector led to marked reduction in Th17 responses and robust inhibition of incidence, severity, and histopathology of disease, independently of IFN-gamma. The disease-limiting action of IL-18bp included suppression of APC-derived Th17-polarizing cytokines. IL-18bp thus acts as a sensor for IFN-gamma and can regulate both Th1 and Th17 responses in the CNS. The Journal of Immunology, 2010, 185: 2458-2466.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available